Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor Model.

Niknam S, Barsoumian HB, Schoenhals JE, Jackson HL, Yanamandra N, Caetano MS, Li A, Younes AI, Cadena A, Cushman TR, Chang JY, Nguyen QN, Gomez DR, Diab A, Heymach JV, Hwu P, Cortez MA, Welsh JW.

Clin Cancer Res. 2018 May 21. doi: 10.1158/1078-0432.CCR-17-3279. [Epub ahead of print]

PMID:
29784675
2.

Outcome of ovarian drilling in women with polycystic ovary syndrome.

Yanamandra NK, Gundabattula SR.

J Clin Diagn Res. 2015 Feb;9(2):QC01-3. doi: 10.7860/JCDR/2015/8001.5586. Epub 2015 Feb 1.

3.

Tipifarnib-induced apoptosis in acute myeloid leukemia and multiple myeloma cells depends on Ca2+ influx through plasma membrane Ca2+ channels.

Yanamandra N, Buzzeo RW, Gabriel M, Hazlehurst LA, Mari Y, Beaupre DM, Cuevas J.

J Pharmacol Exp Ther. 2011 Jun;337(3):636-43. doi: 10.1124/jpet.110.172809. Epub 2011 Mar 4.

4.

Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.

Devy L, Huang L, Naa L, Yanamandra N, Pieters H, Frans N, Chang E, Tao Q, Vanhove M, Lejeune A, van Gool R, Sexton DJ, Kuang G, Rank D, Hogan S, Pazmany C, Ma YL, Schoonbroodt S, Nixon AE, Ladner RC, Hoet R, Henderikx P, Tenhoor C, Rabbani SA, Valentino ML, Wood CR, Dransfield DT.

Cancer Res. 2009 Feb 15;69(4):1517-26. doi: 10.1158/0008-5472.CAN-08-3255. Epub 2009 Feb 10.

6.

Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia.

Yanamandra N, Colaco NM, Parquet NA, Buzzeo RW, Boulware D, Wright G, Perez LE, Dalton WS, Beaupre DM.

Clin Cancer Res. 2006 Jan 15;12(2):591-9.

7.

Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastoma.

Reddy CD, Patti R, Guttapalli A, Maris JM, Yanamandra N, Rachamallu A, Sutton LN, Phillips PC, Posner GH.

J Cell Biochem. 2006 Jan 1;97(1):198-206.

PMID:
16200638
8.

Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line.

Yanamandra N, Kondraganti S, Gondi CS, Gujrati M, Olivero WC, Dinh DH, Rao JS.

Int J Cancer. 2005 Jul 20;115(6):998-1005.

9.

Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.

Gondi CS, Lakka SS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Tung CH, Weissleder R, Rao JS.

Cancer Res. 2004 Jun 15;64(12):4069-77.

10.

Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.

Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS.

Oncogene. 2004 Jun 10;23(27):4681-9.

PMID:
15122332
11.

Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells.

Yanamandra N, Kondraganti S, Srinivasula SM, Gujrati M, Olivero WC, Dinh DH, Rao JS.

Oncogene. 2004 Mar 25;23(13):2339-46.

PMID:
14767475
12.

Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis.

Yanamandra N, Gumidyala KV, Waldron KG, Gujrati M, Olivero WC, Dinh DH, Rao JS, Mohanam S.

Oncogene. 2004 Mar 18;23(12):2224-30.

PMID:
14730346
13.

Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.

Gondi CS, Lakka SS, Yanamandra N, Siddique K, Dinh DH, Olivero WC, Gujrati M, Rao JS.

Oncogene. 2003 Sep 4;22(38):5967-75.

PMID:
12955075
14.

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS.

Oncogene. 2003 Jul 17;22(29):4509-16.

PMID:
12881707
15.

Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells.

Yanamandra N, Berhow MA, Konduri S, Dinh DH, Olivero WC, Nicolson GL, Rao JS.

Clin Exp Metastasis. 2003;20(4):375-83.

PMID:
12856725
17.

Physiological and chemical inducers of tissue factor pathway inhibitor-2 in human glioma cells.

Konduri SD, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Rao JS.

Int J Oncol. 2003 Jun;22(6):1277-83.

PMID:
12738994
18.

Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.

Siddique K, Yanamandra N, Gujrati M, Dinh D, Rao JS, Olivero W.

Int J Oncol. 2003 Feb;22(2):289-94.

PMID:
12527924
19.

Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells.

Konduri SD, Yanamandra N, Siddique K, Joseph A, Dinh DH, Olivero WC, Gujrati M, Kouraklis G, Swaroop A, Kyritsis AP, Rao JS.

Oncogene. 2002 Dec 12;21(57):8705-12.

20.

Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.

Lakka SS, Rajan M, Gondi C, Yanamandra N, Chandrasekar N, Jasti SL, Adachi Y, Siddique K, Gujrati M, Olivero W, Dinh DH, Kouraklis G, Kyritsis AP, Rao JS.

Oncogene. 2002 Nov 14;21(52):8011-9.

21.

Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.

Mohanam S, Chandrasekar N, Yanamandra N, Khawar S, Mirza F, Dinh DH, Olivero WC, Rao JS.

Oncogene. 2002 Nov 7;21(51):7824-30.

22.

The mutational spectrum of brachydactyly type C.

Everman DB, Bartels CF, Yang Y, Yanamandra N, Goodman FR, Mendoza-Londono JR, Savarirayan R, White SM, Graham JM Jr, Gale RP, Svarch E, Newman WG, Kleckers AR, Francomano CA, Govindaiah V, Singh L, Morrison S, Thomas JT, Warman ML.

Am J Med Genet. 2002 Oct 15;112(3):291-6.

PMID:
12357473
23.

Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.

Konduri SD, Osman FA, Rao CN, Srinivas H, Yanamandra N, Tasiou A, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Kouraklis G, Rao JS.

Oncogene. 2002 Jan 31;21(6):921-8.

24.

Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.

Adachi Y, Chandrasekar N, Kin Y, Lakka SS, Mohanam S, Yanamandra N, Mohan PM, Fuller GN, Fang B, Fueyo J, Dinh DH, Olivero WC, Tamiya T, Ohmoto T, Kyritsis AP, Rao JS.

Oncogene. 2002 Jan 3;21(1):87-95.

25.

Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells.

Yanamandra N, Konduri SD, Mohanam S, Dinh DH, Olivero WC, Gujrati M, Nicolson GL, Obeyeseke M, Rao JS.

Clin Exp Metastasis. 2000;18(7):611-5.

PMID:
11688967
26.

Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes.

Adachi Y, Lakka SS, Chandrasekar N, Yanamandra N, Gondi CS, Mohanam S, Dinh DH, Olivero WC, Gujrati M, Tamiya T, Ohmoto T, Kouraklis G, Aggarwal B, Rao JS.

J Biol Chem. 2001 Dec 14;276(50):47171-7. Epub 2001 Sep 25.

27.

A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas.

Tasiou A, Konduri SD, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Obeyesekere M, Rao JS.

Int J Oncol. 2001 Sep;19(3):591-7.

PMID:
11494041
28.

Elevated levels of cathepsin B in human glioblastoma cell lines.

Konduri S, Lakka SS, Tasiou A, Yanamandra N, Gondi CS, Dinh DH, Olivero WC, Gujrati M, Rao JS.

Int J Oncol. 2001 Sep;19(3):519-24.

PMID:
11494030

Supplemental Content

Loading ...
Support Center